Evidence map›Paper›PMID 42444849›Full record

ArticleJournal of thoracic disease2026

Thoracic

Zhuoying Su, Guiyang Chen, Fengmei Zhong, Bin Liu, Shuhong Wu, Fu Rong, Yanhua Lv, Xi Li

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhuoying SuDepartment of Respiratory and Critical Care Medicine, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China.ORCID https://orcid.org/0000-0002-2092-7693
Guiyang ChenDepartment of Respiratory and Critical Care Medicine, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China.
Fengmei ZhongDepartment of Pathology, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China.
Bin LiuDepartment of Respiratory and Critical Care Medicine, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China.
Shuhong WuDepartment of Respiratory and Critical Care Medicine, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China.
Fu RongDepartment of Respiratory and Critical Care Medicine, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China.
Yanhua LvDepartment of Respiratory and Critical Care Medicine, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China.
Xi LiDepartment of Respiratory and Critical Care Medicine, The Eighth Affiliated Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Thoracic Methods: A systematic literature search was performed in PubMed, Embase, and Web of Science from database inception to November 30, 2024, in accordance with PRISMA guidelines. Individual patient data were extracted from eligible published case reports and case series and pooled for unified survival analysis. Aggregated survival data from retrospective cohort studies were summarized for cross-study comparison. Overall survival (OS) was analyzed using the Kaplan-Meier method, and treatment-specific outcomes were visualized using swimmer plots and forest plots. Results: A total of 32 studies comprising 239 patients with thoracic Conclusions: Our analysis suggests that combination therapy based on ICIs correlates with better survival in thoracic

Indexed as

immune checkpoint inhibitor (ICI)meta-analysisoverall survival (OS)SMARCA4-deficient undifferentiated tumor (SMARCA4-UT)thoracic tumor

Identifiers

PMID42444849
PMCPMC13358531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.